These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9114194)

  • 1. Atovaquone for salvage treatment and suppression of toxoplasmic encephalitis in patients with AIDS. Atovaquone/Toxoplasmic Encephalitis Study Group.
    Torres RA; Weinberg W; Stansell J; Leoung G; Kovacs J; Rogers M; Scott J
    Clin Infect Dis; 1997 Mar; 24(3):422-9. PubMed ID: 9114194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atovaquone as long-term suppressive therapy for toxoplasmic encephalitis in patients with AIDS and multiple drug intolerance. Atovaquone Expanded Access Group.
    Katlama C; Mouthon B; Gourdon D; Lapierre D; Rousseau F
    AIDS; 1996 Sep; 10(10):1107-12. PubMed ID: 8874627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atovaquone maintenance therapy prevents reactivation of toxoplasmic encephalitis in a murine model of reactivated toxoplasmosis.
    Dunay IR; Heimesaat MM; Bushrab FN; Müller RH; Stocker H; Arasteh K; Kurowski M; Fitzner R; Borner K; Liesenfeld O
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4848-54. PubMed ID: 15561866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of rifabutin in combination with atovaquone, clindamycin, pyrimethamine, or sulfadiazine for treatment of toxoplasmic encephalitis in mice.
    Araujo FG; Suzuki Y; Remington JS
    Eur J Clin Microbiol Infect Dis; 1996 May; 15(5):394-7. PubMed ID: 8793398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Recherche sur le SIDA, Essai 039.
    Chirgwin K; Hafner R; Leport C; Remington J; Andersen J; Bosler EM; Roque C; Rajicic N; McAuliffe V; Morlat P; Jayaweera DT; Vilde JL; Luft BJ
    Clin Infect Dis; 2002 May; 34(9):1243-50. PubMed ID: 11941551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrice-weekly sulfadiazine-pyrimethamine for maintenance therapy of toxoplasmic encephalitis in HIV-infected patients. Spanish Toxoplasmosis Study Group.
    Podzamczer D; Miró JM; Ferrer E; Gatell JM; Ramón JM; Ribera E; Sirera G; Cruceta A; Knobel H; Domingo P; Polo R; Leyes M; Cosin J; Fariñas MC; Arrizabalaga J; Martínez-Lacasa J; Gudiol F
    Eur J Clin Microbiol Infect Dis; 2000 Feb; 19(2):89-95. PubMed ID: 10746493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of atovaquone in resistant toxoplasmosis in AIDS].
    Lafeuillade A; Pellegrino P; Poggi C; Profizi N; Quilichini R; Chouette I; Navarreté MS
    Presse Med; 1993 Oct; 22(33):1708. PubMed ID: 8278330
    [No Abstract]   [Full Text] [Related]  

  • 8. Failure of atovaquone in the treatment of cerebral toxoplasmosis.
    Durand JM; Cretel E; Bagneres D; Guillemot E; Kaplanski G; Soubeyrand J
    AIDS; 1995 Jul; 9(7):812-3. PubMed ID: 7546430
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug treatment of toxoplasmic encephalitis in acquired immunodeficiency syndrome.
    Winstanley P
    Postgrad Med J; 1995 Jul; 71(837):404-8. PubMed ID: 7567731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atovaquone: a review.
    Haile LG; Flaherty JF
    Ann Pharmacother; 1993 Dec; 27(12):1488-94. PubMed ID: 8305784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desensitization to trimethoprim-sulfamethoxazole in a toxoplasmic encephalitis patient who was intolerant to conventional treatments.
    Miyata N; Yoshimura Y; Hikosaka K; Norose K; Tachikawa N
    J Infect Chemother; 2020 Mar; 26(3):289-293. PubMed ID: 31711832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled trial of pyrimethamine plus sulfadiazine versus trimethoprim plus sulfamethoxazole for treatment of toxoplasmic encephalitis in AIDS patients.
    Kongsaengdao S; Samintarapanya K; Oranratnachai K; Prapakarn W; Apichartpiyakul C
    J Int Assoc Physicians AIDS Care (Chic); 2008; 7(1):11-6. PubMed ID: 17517949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxycycline and pyrimethamine for toxoplasmic encephalitis.
    Hagberg L; Palmertz B; Lindberg J
    Scand J Infect Dis; 1993; 25(1):157-60. PubMed ID: 8460343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of Clindamycin and Azithromycin as Alternative Treatment for Toxoplasma gondii Encephalitis.
    Shiojiri D; Kinai E; Teruya K; Kikuchi Y; Oka S
    Emerg Infect Dis; 2019 Apr; 25(4):841-843. PubMed ID: 30882331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic alternatives for cases of cerebral toxoplasmosis in patients with AIDS: clarithromycin and atovaquone].
    Guelar A; Miró JM; Mallolas J; Zamora L; Cardenal C; Gatell JM; Soriano E
    Enferm Infecc Microbiol Clin; 1994 Mar; 12(3):137-40. PubMed ID: 8011719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atovaquone. A review of its pharmacological properties and therapeutic efficacy in opportunistic infections.
    Spencer CM; Goa KL
    Drugs; 1995 Jul; 50(1):176-96. PubMed ID: 7588086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral toxoplasmosis in childhood and adult HIV infection treated with 1-4 hydroxynaphthoquinone and rapid desensitization with pyrimethamine.
    Bouboulis DA; Rubinstein A; Shliozberg J; Madden J; Frieri M
    Ann Allergy Asthma Immunol; 1995 Jun; 74(6):491-4. PubMed ID: 7788516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of toxoplasmosis retinochoroiditis with atovaquone in an AIDS patient].
    Schimkat M; Althaus C; Armbrecht C; Jablonowski H; Sundmacher R
    Klin Monbl Augenheilkd; 1995 Mar; 206(3):173-7. PubMed ID: 7616727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rifabutin is active in murine models of toxoplasmosis.
    Araujo FG; Slifer T; Remington JS
    Antimicrob Agents Chemother; 1994 Mar; 38(3):570-5. PubMed ID: 8203856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The activity of atovaquone (566C80) in murine toxoplasmosis is markedly augmented when used in combination with pyrimethamine or sulfadiazine.
    Araujo FG; Lin T; Remington JS
    J Infect Dis; 1993 Feb; 167(2):494-7. PubMed ID: 8421189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.